Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Mazdutide

A Study of IBI362 Evaluating Weight Loss in Obese and Overweight Chinese Subjects

Innovent · Phase 2 · Completed · Enrollment 328

NCT04904913

ArmPopulationDoseWeeksEstimandWeight change
IBI362 high doseObesity or overweightn/r24n/rn/r
IBI362 low doseObesity or overweightn/r24n/rn/r
placeboObesity or overweightn/r24n/rn/r
IBI362 moderate doseObesity or overweightn/r24n/rn/r
IBI362 extra high doseObesity or overweightn/r24n/rn/r